Clinical trial
Ceprotin Treatment Registry
NCT01127529 is registered in ClinicalTrials.gov with Baxalta now part of Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ceprotin Treatment Registry
- Lead sponsor
- Baxalta now part of Shire
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 23, 2010
- Completion date
- June 22, 2015
- Enrollment
- 43 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.